Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Feb;73(856):69–74. doi: 10.1136/pgmj.73.856.69

Paget's disease of bone.

C G Ooi 1, W D Fraser 1
PMCID: PMC2431220  PMID: 9122100

Abstract

Paget's disease of bone is a relatively common condition in the UK affecting up to 5% of the population over the age of 55 years with particularly high prevalence in the North West of England. The majority of those affected are asymptomatic. Its precise cause remains unknown, and until recently, choice of treatment of this sometimes painful and debilitating disease has been limited. In this article, we review various aspects of this disease, concentrating particularly on recent advances in our understanding of its aetiology and its treatment.

Full text

PDF
69

Images in this article

70Figure 1
on p.70
70Figure 2
on p.70
71Figure 3
on p.71

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami S., Mian M., Gatti P., Rossini M., Zamberlan N., Bertoldo F., Lo Cascio V. Effects of two oral doses of alendronate in the treatment of Paget's disease of bone. Bone. 1994 Jul-Aug;15(4):415–417. doi: 10.1016/8756-3282(94)90818-4. [DOI] [PubMed] [Google Scholar]
  2. Adamson B. B., Gallacher S. J., Byars J., Ralston S. H., Boyle I. T., Boyce B. F. Mineralisation defects with pamidronate therapy for Paget's disease. Lancet. 1993 Dec 11;342(8885):1459–1460. doi: 10.1016/0140-6736(93)92935-m. [DOI] [PubMed] [Google Scholar]
  3. Altman R. D. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone. Am J Med. 1985 Nov;79(5):583–590. doi: 10.1016/0002-9343(85)90055-5. [DOI] [PubMed] [Google Scholar]
  4. Alvarez L., Guañabens N., Peris P., Monegal A., Bedini J. L., Deulofeu R., Martinez de Osaba M. J., Muñoz-Gomez J., Rivera-Fillat F., Ballesta A. M. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J Bone Miner Res. 1995 Mar;10(3):458–465. doi: 10.1002/jbmr.5650100318. [DOI] [PubMed] [Google Scholar]
  5. Barker D. J., Detheridge F. M. Dogs and Paget's disease. Lancet. 1985 Nov 30;2(8466):1245–1245. doi: 10.1016/s0140-6736(85)90774-3. [DOI] [PubMed] [Google Scholar]
  6. Barker D. J. The epidemiology of Paget's disease of bone. Br Med Bull. 1984 Oct;40(4):396–400. doi: 10.1093/oxfordjournals.bmb.a072011. [DOI] [PubMed] [Google Scholar]
  7. Baslé M. F., Fournier J. G., Rozenblatt S., Rebel A., Bouteille M. Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol. 1986 May;67(Pt 5):907–913. doi: 10.1099/0022-1317-67-5-907. [DOI] [PubMed] [Google Scholar]
  8. Baslé M. F., Rebel A., Fournier J. G., Russell W. C., Malkani K. On the trail of paramyxoviruses in Paget's disease of bone. Clin Orthop Relat Res. 1987 Apr;(217):9–15. [PubMed] [Google Scholar]
  9. Bianco P., Silvestrini G., Ballanti P., Bonucci E. Paramyxovirus-like nuclear inclusions identical to those of Paget's disease of bone detected in giant cells of primary oxalosis. Virchows Arch A Pathol Anat Histopathol. 1992;421(5):427–433. doi: 10.1007/BF01606916. [DOI] [PubMed] [Google Scholar]
  10. Birch M. A., Ginty A. F., Walsh C. A., Fraser W. D., Gallagher J. A., Bilbe G. PCR detection of cytokines in normal human and pagetic osteoblast-like cells. J Bone Miner Res. 1993 Oct;8(10):1155–1162. doi: 10.1002/jbmr.5650081002. [DOI] [PubMed] [Google Scholar]
  11. Birch M. A., Taylor W., Fraser W. D., Ralston S. H., Hart C. A., Gallagher J. A. Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J Bone Miner Res. 1994 Jan;9(1):11–16. doi: 10.1002/jbmr.5650090103. [DOI] [PubMed] [Google Scholar]
  12. Bockman R. S., Wilhelm F., Siris E., Singer F., Chausmer A., Bitton R., Kotler J., Bosco B. J., Eyre D. R., Levenson D. A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone. J Clin Endocrinol Metab. 1995 Feb;80(2):595–602. doi: 10.1210/jcem.80.2.7852526. [DOI] [PubMed] [Google Scholar]
  13. Bombassei G. J., Yocono M., Raisz L. G. Effects of intravenous pamidronate therapy on Paget's disease of bone. Am J Med Sci. 1994 Oct;308(4):226–233. doi: 10.1097/00000441-199430840-00003. [DOI] [PubMed] [Google Scholar]
  14. Fitton A., McTavish D. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs. 1991 Feb;41(2):289–318. doi: 10.2165/00003495-199141020-00009. [DOI] [PubMed] [Google Scholar]
  15. Gennari C., Sensini I. Letter: Diphosphonate therapy in deafness associated with Paget's disease. Br Med J. 1975 Feb 8;1(5953):331–331. doi: 10.1136/bmj.1.5953.331-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gordon M. T., Cartwright E. J., Mercer S., Anderson D. C., Sharpe P. T. HLA polymorphisms in Paget's disease of bone. Semin Arthritis Rheum. 1994 Feb;23(4):229–229. doi: 10.1016/0049-0172(94)90040-x. [DOI] [PubMed] [Google Scholar]
  17. Gordon M. T., Mee A. P., Anderson D. C., Sharpe P. T. Canine distemper virus transcripts sequenced from pagetic bone. Bone Miner. 1992 Nov;19(2):159–174. doi: 10.1016/0169-6009(92)90923-2. [DOI] [PubMed] [Google Scholar]
  18. Hadjipavlou A., Lander P., Srolovitz H., Enker I. P. Malignant transformation in Paget disease of bone. Cancer. 1992 Dec 15;70(12):2802–2808. doi: 10.1002/1097-0142(19921215)70:12<2802::aid-cncr2820701213>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  19. Harinck H. I., Bijvoet O. L., Blanksma H. J., Dahlinghaus-Nienhuys P. J. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin Orthop Relat Res. 1987 Apr;(217):79–98. [PubMed] [Google Scholar]
  20. Hoyland J. A., Freemont A. J., Sharpe P. T. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res. 1994 Jan;9(1):75–80. doi: 10.1002/jbmr.5650090111. [DOI] [PubMed] [Google Scholar]
  21. Hoyland J., Sharpe P. T. Upregulation of c-fos protooncogene expression in pagetic osteoclasts. J Bone Miner Res. 1994 Aug;9(8):1191–1194. doi: 10.1002/jbmr.5650090808. [DOI] [PubMed] [Google Scholar]
  22. Johnston C. C., Jr, Altman R. D., Canfield R. E., Finerman G. A., Taulbee J. D., Ebert M. L. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). Clin Orthop Relat Res. 1983 Jan-Feb;(172):186–194. [PubMed] [Google Scholar]
  23. Khairi M. R., Altman R. D., DeRosa G. P., Zimmermann J., Schenk R. K., Johnston C. C. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Ann Intern Med. 1977 Dec;87(6):656–663. doi: 10.7326/0003-4819-87-6-656. [DOI] [PubMed] [Google Scholar]
  24. Khan S., McCloskey E. V., Eyres K. S., Fern E. D., Kanis J. A. Assessment of optimum duration of therapy with oral dichloromethylene diphosphonate (clodronate) in the treatment of Paget's disease. Semin Arthritis Rheum. 1994 Feb;23(4):271–271. doi: 10.1016/0049-0172(94)90059-0. [DOI] [PubMed] [Google Scholar]
  25. Macarol V., Fraunfelder F. T. Pamidronate disodium and possible ocular adverse drug reactions. Am J Ophthalmol. 1994 Aug 15;118(2):220–224. doi: 10.1016/s0002-9394(14)72902-2. [DOI] [PubMed] [Google Scholar]
  26. Meunier P. J., Coindre J. M., Edouard C. M., Arlot M. E. Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum. 1980 Oct;23(10):1095–1103. doi: 10.1002/art.1780231005. [DOI] [PubMed] [Google Scholar]
  27. Meunier P. J., Salson C., Mathieu L., Chapuy M. C., Delmas P., Alexandre C., Charhon S. Skeletal distribution and biochemical parameters of Paget's disease. Clin Orthop Relat Res. 1987 Apr;(217):37–44. [PubMed] [Google Scholar]
  28. Mii Y., Miyauchi Y., Honoki K., Morishita T., Miura S., Aoki M., Tamai S., Tsunoda S., Nishitani M., Sakaki T. Electron microscopic evidence of a viral nature for osteoclast inclusions in Paget's disease of bone. Virchows Arch. 1994;424(1):99–104. doi: 10.1007/BF00197399. [DOI] [PubMed] [Google Scholar]
  29. Mills B. G., Frausto A., Singer F. R., Ohsaki Y., Demulder A., Roodman G. D. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens. Bone. 1994 Jul-Aug;15(4):443–448. doi: 10.1016/8756-3282(94)90823-0. [DOI] [PubMed] [Google Scholar]
  30. Mills B. G., Singer F. R., Weiner L. P., Suffin S. C., Stabile E., Holst P. Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop Relat Res. 1984 Mar;(183):303–311. [PubMed] [Google Scholar]
  31. O'Doherty D. P., McCloskey E. V., Vasikaran S., Khan S., Kanis J. A. The effects of intravenous alendronate in Paget's disease of bone. J Bone Miner Res. 1995 Jul;10(7):1094–1100. doi: 10.1002/jbmr.5650100714. [DOI] [PubMed] [Google Scholar]
  32. O'Driscoll J. B., Buckler H. M., Jeacock J., Anderson D. C. Dogs, distemper and osteitis deformans: a further epidemiological study. Bone Miner. 1990 Nov;11(2):209–216. doi: 10.1016/0169-6009(90)90060-s. [DOI] [PubMed] [Google Scholar]
  33. Paget J. On a Form of Chronic Inflammation of Bones (Osteitis Deformans). Med Chir Trans. 1877;60:37–64.9. doi: 10.1177/095952877706000105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Plosker G. L., Goa K. L. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs. 1994 Jun;47(6):945–982. doi: 10.2165/00003495-199447060-00007. [DOI] [PubMed] [Google Scholar]
  35. ROSENKRANTZ J. A., WOLF J., KAICHER J. J. Paget's disease (osteitis deformans); review of one hundred eleven cases. AMA Arch Intern Med. 1952 Nov;90(5):610–633. doi: 10.1001/archinte.1952.00240110036005. [DOI] [PubMed] [Google Scholar]
  36. Ralston S. H., Digiovine F. S., Gallacher S. J., Boyle I. T., Duff G. W. Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction. J Bone Miner Res. 1991 Nov;6(11):1243–1248. doi: 10.1002/jbmr.5650061115. [DOI] [PubMed] [Google Scholar]
  37. Ralston S. H., Hoey S. A., Gallacher S. J., Adamson B. B., Boyle I. T. Cytokine and growth factor expression in Paget's disease: analysis by reverse-transcription/polymerase chain reaction. Br J Rheumatol. 1994 Jul;33(7):620–625. doi: 10.1093/rheumatology/33.7.620. [DOI] [PubMed] [Google Scholar]
  38. Ramsay H. A., Linthicum F. H., Jr Cochlear histopathology in Paget's disease. Am J Otolaryngol. 1993 Jan-Feb;14(1):60–61. doi: 10.1016/0196-0709(93)90013-w. [DOI] [PubMed] [Google Scholar]
  39. Rebel A., Malkani K., Basle M. Anomalies nucléaires des ostéoclastes de la maladie osseuse de Paget. Nouv Presse Med. 1974 May 18;3(20):1299–1301. [PubMed] [Google Scholar]
  40. Reginster J. Y., Jeugmans-Huynen A. M., Wouters M., Sarlet N., McIntyre H. D., Franchimont P. The effect of nasal hCT on bone turnover in Paget's disease of bone--implications for the treatment of other metabolic bone diseases. Br J Rheumatol. 1992 Jan;31(1):35–39. doi: 10.1093/rheumatology/31.1.35. [DOI] [PubMed] [Google Scholar]
  41. Reginster J. Y., Treves R., Renier J. C., Amor B., Sany J., Ethgen D., Picot C., Franchimont P. Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone. J Bone Miner Res. 1994 May;9(5):615–619. doi: 10.1002/jbmr.5650090505. [DOI] [PubMed] [Google Scholar]
  42. Reid I. R., Cundy T., Ibbertson H. K., King A. R. Osteomalacia after pamidronate for Paget's disease. Lancet. 1994 Apr 2;343(8901):855–855. doi: 10.1016/s0140-6736(94)92055-9. [DOI] [PubMed] [Google Scholar]
  43. Rongstad K. M., Wheeler D. L., Enneking W. F. A comparison of the amount of vascularity in pagetic and normal human bone. Clin Orthop Relat Res. 1994 Sep;(306):247–249. [PubMed] [Google Scholar]
  44. Roodman G. D., Kurihara N., Ohsaki Y., Kukita A., Hosking D., Demulder A., Smith J. F., Singer F. R. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992 Jan;89(1):46–52. doi: 10.1172/JCI115584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ryan W. G., Schwartz T. B. Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy. Arthritis Rheum. 1980 Oct;23(10):1155–1161. doi: 10.1002/art.1780231013. [DOI] [PubMed] [Google Scholar]
  46. Singer F. R., Fredericks R. S., Minkin C. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. Arthritis Rheum. 1980 Oct;23(10):1148–1154. doi: 10.1002/art.1780231012. [DOI] [PubMed] [Google Scholar]
  47. Siris E. S., Clemens T. P., McMahon D., Gordon A., Jacobs T. P., Canfield R. E. Parathyroid function in Paget's disease of bone. J Bone Miner Res. 1989 Feb;4(1):75–79. doi: 10.1002/jbmr.5650040111. [DOI] [PubMed] [Google Scholar]
  48. Siris E. S., Ottman R., Flaster E., Kelsey J. L. Familial aggregation of Paget's disease of bone. J Bone Miner Res. 1991 May;6(5):495–500. doi: 10.1002/jbmr.5650060511. [DOI] [PubMed] [Google Scholar]
  49. Solomon L. R., Evanson J. M., Canty D. P., Gill N. W. Effect of calcitonin treatment on deafness due to Paget's disease of bone. Br Med J. 1977 Aug 20;2(6085):485–487. doi: 10.1136/bmj.2.6085.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Strickberger S. A., Schulman S. P., Hutchins G. M. Association of Paget's disease of bone with calcific aortic valve disease. Am J Med. 1987 May;82(5):953–956. doi: 10.1016/0002-9343(87)90157-4. [DOI] [PubMed] [Google Scholar]
  51. The classic. Osteoclast ultrastructure in Paget's disease. By A. Rebel, K. Malkani, M. Baslé, and Ch. Bregeon. 1976. Clin Orthop Relat Res. 1987 Apr;(217):4–8. [PubMed] [Google Scholar]
  52. Tilyard M. W., Gardner R. J., Milligan L., Cleary T. A., Stewart R. D. A probable linkage between familial Paget's disease and the HLA loci. Aust N Z J Med. 1982 Oct;12(5):498–500. doi: 10.1111/j.1445-5994.1982.tb03830.x. [DOI] [PubMed] [Google Scholar]
  53. Waltner J. G. Stapedectomy in Paget's disease. Histological and clinical studies. Arch Otolaryngol. 1965 Oct;82(4):355–358. doi: 10.1001/archotol.1965.00760010357004. [DOI] [PubMed] [Google Scholar]
  54. Wells C., Woodhouse N. Paget's disease in an Anglo-Saxon. Med Hist. 1975 Oct;19(4):396–400. doi: 10.1017/s0025727300020524. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES